Fideuram Intesa Sanpaolo Private Banking S.P.A. bought a new position in shares of Marsh & McLennan Companies, Inc. (NYSE:MRSH – Free Report) in the fourth quarter, HoldingsChannel reports. The firm bought 10,370 shares of the financial services provider’s stock, valued at approximately $1,924,000.
A number of other institutional investors also recently modified their holdings of the company. Numerai GP LLC raised its stake in Marsh & McLennan Companies by 966.2% in the third quarter. Numerai GP LLC now owns 37,220 shares of the financial services provider’s stock worth $7,501,000 after buying an additional 33,729 shares in the last quarter. Rockland Trust Co. raised its stake in Marsh & McLennan Companies by 801.6% in the third quarter. Rockland Trust Co. now owns 12,073 shares of the financial services provider’s stock worth $2,433,000 after buying an additional 10,734 shares in the last quarter. Swiss Life Asset Management Ltd raised its stake in Marsh & McLennan Companies by 9.5% in the fourth quarter. Swiss Life Asset Management Ltd now owns 134,542 shares of the financial services provider’s stock worth $24,960,000 after buying an additional 11,648 shares in the last quarter. Barclays PLC raised its stake in Marsh & McLennan Companies by 41.7% in the third quarter. Barclays PLC now owns 2,202,372 shares of the financial services provider’s stock worth $443,844,000 after buying an additional 647,987 shares in the last quarter. Finally, Bridges Investment Management Inc. raised its stake in Marsh & McLennan Companies by 4.4% in the third quarter. Bridges Investment Management Inc. now owns 76,196 shares of the financial services provider’s stock worth $15,356,000 after buying an additional 3,177 shares in the last quarter. 87.99% of the stock is currently owned by hedge funds and other institutional investors.
Insider Transactions at Marsh & McLennan Companies
In related news, CEO John Q. Doyle sold 16,655 shares of the firm’s stock in a transaction that occurred on Wednesday, March 4th. The shares were sold at an average price of $183.30, for a total value of $3,052,861.50. Following the sale, the chief executive officer owned 116,811 shares in the company, valued at approximately $21,411,456.30. This trade represents a 12.48% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Corporate insiders own 0.38% of the company’s stock.
Marsh & McLennan Companies Stock Performance
Marsh & McLennan Companies (NYSE:MRSH – Get Free Report) last announced its earnings results on Thursday, April 16th. The financial services provider reported $3.29 earnings per share for the quarter, beating analysts’ consensus estimates of $3.21 by $0.08. Marsh & McLennan Companies had a net margin of 14.26% and a return on equity of 31.87%. The business had revenue of $7.30 billion during the quarter. The firm’s revenue for the quarter was up 7.6% compared to the same quarter last year. On average, analysts forecast that Marsh & McLennan Companies, Inc. will post 10.37 earnings per share for the current fiscal year.
Marsh & McLennan Companies Dividend Announcement
The business also recently announced a quarterly dividend, which was paid on Friday, May 15th. Investors of record on Thursday, April 9th were issued a $0.90 dividend. The ex-dividend date was Thursday, April 9th. This represents a $3.60 annualized dividend and a yield of 2.2%. Marsh & McLennan Companies’s dividend payout ratio (DPR) is currently 45.00%.
Analysts Set New Price Targets
A number of equities analysts recently issued reports on the stock. Wells Fargo & Company decreased their price target on shares of Marsh & McLennan Companies from $203.00 to $178.00 and set an “equal weight” rating for the company in a research note on Thursday, April 9th. Citigroup raised shares of Marsh & McLennan Companies from a “neutral” rating to a “buy” rating and set a $200.00 price target for the company in a research note on Wednesday, May 6th. Barclays decreased their price target on shares of Marsh & McLennan Companies from $209.00 to $206.00 and set an “overweight” rating for the company in a research note on Wednesday, April 8th. Raymond James Financial raised shares of Marsh & McLennan Companies from an “outperform” rating to a “strong-buy” rating and set a $225.00 target price for the company in a research note on Tuesday, February 17th. Finally, Morgan Stanley decreased their target price on shares of Marsh & McLennan Companies from $195.00 to $190.00 and set an “equal weight” rating for the company in a research note on Monday, April 6th. One analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating, nine have given a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of “Hold” and an average price target of $205.00.
Check Out Our Latest Report on MRSH
About Marsh & McLennan Companies
Marsh & McLennan Companies (NYSE: MMC) is a global professional services firm headquartered in New York City that provides advice and solutions in the areas of risk, strategy and people. Founded in 1905, the company has grown into a diversified group of businesses focused on insurance brokerage and risk management, reinsurance, human capital and investment consulting, and management consulting. Its long history and scale position it as a prominent adviser to corporations, governments and other institutions seeking to manage risk and optimize human and financial capital.
The firm operates through several well-known subsidiaries and business units that specialize in distinct services.
Featured Stories
- Five stocks we like better than Marsh & McLennan Companies
- Meta Platforms 10% Layoff Raises a Bigger Question About AI Spending
- As Small-Cap Outperformance Continues, These 2 ETFs Provide Exposure
- Silicon Shake-Up: The AI Trade Is Moving Beyond NVIDIA
- The Silver Lining of Last Week’s Hims & Hers Earnings Miss
Want to see what other hedge funds are holding MRSH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Marsh & McLennan Companies, Inc. (NYSE:MRSH – Free Report).
Receive News & Ratings for Marsh & McLennan Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Marsh & McLennan Companies and related companies with MarketBeat.com's FREE daily email newsletter.
